Browsed by
Author: MTC POV

Keeping Your Team Together Remotely

Keeping Your Team Together Remotely

Teamwork is undeniably important when it comes to being successful in the life sciences sector. Prior to the COVID-19 pandemic, organizations were moving towards a more agile way of working. Technology was starting to be used to connect people around the world so that talented life science professionals could collaborate. This was still in its infancy for most areas before the pandemic, with the changing world forcing organizations to become more agile and allow for remote working almost overnight.

Remote Teams are Becoming the Default

One of the biggest changes to the way people have been working in life sciences is that teams have become separated. People have needed to work within the guidelines for social distancing and remote working has become the norm for many people.

Remote working manifests itself in different ways and includes working from home for much of the working day, being placed into smaller team groups or reducing the amount of time spent in the company of others by holding virtual meetings and sharing more work through digital channels. Ultimately, the more we get used to working remotely, the more creative we need to become to meet all workload tasks.

Managing a Dispersed Workforce

Remote working brings many challenges, and this is particularly true for mangers or executives who need to ensure teams work effectively and maintain positive team culture, even when teammates aren’t spending time together.

A dispersed workforce can quickly become a demotivated team, which can lead to people being unhappy in their roles, or even leaving to work for a competitor. As an executive it is likely to fall to you to ensure this does not happen.

Bring Fun to Remote Working

It’s difficult to bring a team together when some people are working remotely and others are in the office. However, if you think about the things that you used to do as a team in the office for fun, you can replicate these. If you usually have cake and sing to someone on their birthday, why not send team members a cake in the post and have a Zoom catch up just for singing and enjoying cake together?

If you often go out as a team after work, arrange to have ‘after work drinks’ virtually. Or if you usually have lunch together, make sure you continue doing these things. People can enjoy a drink or lunch while chatting to colleagues over Zoom. It won’t be the same, but it will bring the team together. 

Focus on the Purpose and Potential

When teams are working remotely, or in a hybrid way, it can be easy for team members to lose sight of the purpose of their work. This is another way that people become demotivated or demoralized quite quickly. When working together, people talk and share aspects of their jobs, meaning that everyone has an insight into the bigger picture. When working remotely, you may need to instigate more regular virtual catch ups so that people have the chance to share what they are doing.

Giving people the opportunity to chat about their work and hear about colleagues’ work will help to ensure employees remain motivated and focused on the purpose of what they are doing. This will also mean that employees can realize their potential by finding out about other opportunities to progress.

Good Morale Achieves a Productive Solution

Maintaining a happy and productive team can be more difficult in the current pandemic climate. However, remote working and hybrid teams are set to stay for the foreseeable future and so implementing ideas now is only going to making working in the future more effective and efficient.

GeneCoda

On Mental Health and Hope: We cannot lose this generation.

On Mental Health and Hope: We cannot lose this generation.

“We cannot lose this generation.” Dr. Kevin Churchwell, president and CEO of Boston Children’s Hospital recently spoke with McKinsey & Company on the pandemic’s impact on children’s health. At first glance, my stomach braced for the same uncomfortable lurch that occurs each time I see or hear “children” and “pandemic” in the same sentence.

In reading through Dr. Churchwell’s take on how we need a continuum of care built upon technology and improved communication for our children, “hope” comes to mind – something not mentioned but implied. I think we must keep “hope” as our guiding star for how we address the pandemic trauma we are presently experiencing-especially for our children. Trauma, like hope, is relevant only in the mind of the beholder. I am not an expert on either but have studied mental health and the brain’s dynamics for a couple of decades. I also have had the lived experience of both.

After 40 years in health care and health information technology (IT), my focus has turned to mental health or more specifically – “brain health” – a nod to the fact that our brain has “plasticity” or can be shaped by external factors. I dodge any reference to “comparable pain” but know I have experienced enough pain to change how my brain reacts to what it interprets to be “trauma”. This change in career focus is different somehow from past career pivots; it somehow feels like mental health– chose me.

In my mind, hope is not an emotion, a resource that can be stockpiled, nor a commodity that everyone has a specific amount of. I chose the best online definition from Miriam Webster:

“Hope is an optimistic state of mind that is based on an expectation of positive outcomes with respect to events and circumstances in one’s life or the world at large.”

After some thought, I realize that the dominance of “hope” in my life–flanked by calm and a certain amount of peace–arrived only after I had spent time examining and “working” on (via counseling, research, and specific therapy) my own perspectives, biases, pain, and expectations.

Psychology Today has a well-stated take on hope:

“Research indicates that hope can help us manage stress and anxiety and cope with adversity. It contributes to our well-being and happiness and motivates positive action.

…. hopeful people do the other things that will help them move toward what they are hoping for.

Then, other positive emotions such as courage and confidence (self-efficacy), and happiness emerge. They become our coping strategy; the emotions crucial in helping us survive. They allow us to take a wider view, become more creative in our approach and problem solving, and retain our optimism.

It doesn’t ignore the trouble, or make excuses, or deny danger. It is not pretending. It is acknowledging the truth of the situation and working to find the best way to cope. It’s showing up and working through the hard stuff, believing that something better is possible. It’s resilient.”

Indeed. We all need that guiding star to convey hope, courage, and confidence to our children. There are reasons to be hopeful.

January 11, 2022|Brain Health, Children and Mental Health, Courage, COVID-19, Digital Mental Health, Hope, Mental Health, Mental Illness, Pandemic, Resilience

Up to Speed: Issue 1, Hypersonics Primer

Up to Speed: Issue 1, Hypersonics Primer

This is the first installment in a new research series from FON Investment Banking that will provide commentary and analysis on developments in the hypersonic weapons industry. This issue is a primer that sets a baseline for the current state of hypersonic weapon development, with more focused reports to follow on hypersonic topics including missile defense, space-based systems, infrastructure, and adversary programs.

Background
Hypersonic weapons – which travel at speeds in excess of Mach 5 (approximately 1 mile per second, or 6,000 kmh) 1 – have been a part of defense research and development in the United States since the 1960s.2 It was during the George W. Bush administration in the early 2000s that the US began to make more targeted investments to develop hypersonic weapons as part of the Conventional Prompt Global Strike (CPGS) program. 3

Hypersonic weapons are typically classified into two categories – hypersonic glide vehicles (“HGV”) and hypersonic cruise missiles (“HCM”):

  • HGVs are unpowered vehicles that are launched from a rocket and then released to glide to its target. These vehicles are maneuverable once they reach the glide phase, therefore holding large areas at risk during flight. Unlike ballistic missiles which can reach upwards of 1,200+ km in altitude, HGVs reach between 40 km to 100 km – flying at trajectories that create significant challenges for existing land- and space-based detection systems and sensor architecture
  • HCMs can be launched from the ground, from aircraft, or from ships. These missiles have airbreathing engines that can produce thrust to hypersonics speeds, known as supersonic combustion ramjet (scramjet) engines. 5 Similar to HGVs, the HCMs combine speed and maneuverability to make them highly effective weapons as compared to conventional cruise missiles.

Hypersonic weapons can be paired with nuclear or conventional warheads, however given their high rate of speed, conventional hypersonic weapons are expected to use only kinetic energy to destroy targets.6 The combination of maneuverability, speed, and flight trajectory not only make this first generation of hypersonic missiles very difficult to detect and defend against, but they materially compress timelines for decisionmakers to assess and respond to the threat once the weapon is in-flight, creating urgency among major governments to have offensive and defensive capabilities. Read More

Breakthrough technology unlocks new frontiers in scientific discovery

Breakthrough technology unlocks new frontiers in scientific discovery

Imagine you need to find a friend inside a crowded stadium, but you don’t have their exact location or a way to contact them. Examining every seat, restroom and food vendor would take hours or maybe days. What if there was a way to sort every single person at that stadium based on their visual traits (e.g., male, brown hair, glasses, beard), so that you could separate out those who do not fit that person’s description into one area and all that do into another area? Then the technology could pull up a high-resolution photo of each person identified as having similar traits, so that you could visually confirm the right person and their location. And you could perform this scan at a rate of 15,000 people per second — or in other words, you could find one person in a stadium of 100,000-plus in under 10 seconds.

For immunologists or functional genomics researchers looking to develop better cancer treatments or personalized medicine—who may often be looking for a needle-in-the-haystack type of rare cell among billions of cells—a new BD technology featured on the Jan. 21, 2022 cover of Science unlocks the potential to do what was previously impossible. In the newly published study, the European Molecular Biology Laboratory (EMBL) and BD demonstrated that this technology identifies at high speeds, not only if and how much of a biomarker is present in a cell, but also a biomarker’s location and other detailed information that could help scientists answer complex biological questions faster.

Why this novel technology represents a landmark advancement for the flow cytometry and cell sorter instruments these scientists rely on

The new technology has the potential to transform immunology, cell biology and genomics research and enable new cell-based therapeutic discovery. Until now, the flow cytometry instruments that researchers relied on to analyze and sort cells enabled them to characterize a large volume of cells for a limited number of traits at a time. For example, current technology allows a researcher to use a dye to make a biomarker on or in the cell that they want to study, such as a protein, fluoresce in a bright color relative to its abundance on or in the individual cells. The lasers that excite the dyes and the corresponding fluorescence emitted enables researcher to know whether the protein is present or not and how many cells had it. However, that was as specific as we had been able to get on this type of high-throughput instrumentation. Researchers seeking more detailed information about specific cells would need to look at individual cells under a microscope to manually identify each one, which is time consuming and is limited by your ability to sort each cell by visual inspection alone.

This breakthrough technology, in essence, marries the high throughput of a flow cytometer with the imaging capability of microscopy followed by cell sorting. By integrating cell imaging and image-based decisioning to sort cells at exceptionally high speeds, it’s now possible to identify, characterize and sort millions of cells in minutes, not hours (or days), based on the visual details of each cell and not solely on the type or quantity of biomarkers that are present. If you could apply this technology to the “find a friend” example, we would be able to sort the entire world’s population of 7.8 billion people in a few days—to learn exactly where on the planet that person was and confirm it was them with an image. The potential this technology has for accelerating research timelines unlocks new dimensions in research and opens the possibility of discovering life-saving drugs and other therapies to patients faster.

Building upon multidisciplinary technologies to create a breakthrough

This technology represents the culmination of more than a decade’s worth of work from a multidisciplinary team of optical, mechanical, electrical, biomedical and software engineers and scientists that aimed to provide researchers a differentiated and flexible capability for analyzing single cells. Taking inspiration from beyond the healthcare space, the R&D team leveraged cutting-edge methodologies from tech-forward fields, such as wireless telecommunications, to create state-of-the art capabilities.

By automating some of the traditionally manual aspects of precision identification, the R&D team from our Biosciences business created a technology that pushes the limits of speed and precision in flow cytometry. The technology can analyze more than 1,000 times the amount of data compared to traditional flow cytometry methods. Named BD CellView™ Image Technology, this technique can capture multiple images of individual cells flowing through the system at speeds up to 15,000 cells per second and also adds a previously impossible capability of sorting cells based on detailed image analysis of individual cells at this speed.

Unlocking new frontiers from research to advancing precision medicine

By enabling scientists to more rapidly view and isolate cells with specific, observable traits of interest, this technology can accelerate discovery research and unlock potential therapies or cures for disease in a broad range of fields, such as virology and oncology—and we’ve just scratched the surface of the types of analyses that are possible. The incredible precision and ease of use for the technology opens new possibilities for researchers in a variety of fields from HIV therapeutics to plant biology. While the full potential for this technology is still unknown, it could transform what’s possible in a wide range of disciplines from immunology to genomics research to cell-based therapeutics and beyond.

BD has been a pioneer in the space since the 1970s, when it became the first company to commercialize flow cytometry technology. Since then, we’ve continued building upon that unparalleled expertise and capabilities leadership, continuing to attract the best and brightest in the field to our R&D team, where they can leverage the breadth and depth of resources BD provides. This team has successfully advanced flow cytometry technology to fill a long-standing gap in research where no other company has. We look forward to working with the scientific community at-large to help them leverage it and advance both research and therapeutic discovery, ultimately advancing the world of health™.

Learn more about why Science chose the study from EMBL and BD as its cover story

How do Carbon Offsets Work?

How do Carbon Offsets Work?

We all have a carbon footprint. Everyday activities like driving your car, using your computer, operating a business, or heating your home generate greenhouse gas emissions that contribute to your carbon footprint which impacts the environment. The best thing we can do to preserve the environment is to take actions to reduce our carbon footprint such as using mass transit and using more efficient lighting and appliances.

However, no matter how much we reduce it’s virtually impossible to avoid all emissions that contribute to our carbon footprint, this is where carbon offsets come in — you can counterbalance or green your unavoidable footprint with CleanSteps®.

Here’s how it works: a business like a landfill or transportation company develops a project that reduces greenhouse gas emissions above and beyond what is already required of them by law. These reductions are measured and verified by independent third parties such at Green-e®.
A carbon offset is then created for every metric ton of carbon dioxide emissions that is reduced from the project. These carbon offsets can be purchased by other individuals and businesses to counterbalance or green their carbon footprint since these projects would not otherwise have been developed. This way, everybody wins.
CleanSteps® is an easy and simple way to reduce your carbon footprint and promote cleaner air and water. The environmental benefit of just one carbon offset compares to taking the average car off the road for about two months or the planting of 16.5 tree saplings that will grow for 10 years.
Ardent Rundown of What to Expect in 2022

Ardent Rundown of What to Expect in 2022

TRUIST Perspective: Rising yield and less Fed accommodation to inject volatility but history suggests primary market trend remains higher

TRUIST Perspective: Rising yield and less Fed accommodation to inject volatility but history suggests primary market trend remains higher

January 6, 2022

What happened?

After a strong start to the year, volatility in markets has risen. Investors appear concerned that the Federal Reserve (Fed) may reduce policy accommodation at a faster rate than previously expected. At the same time, the 10-year U.S. Treasury yield has jumped from a low of 1.35% in late December to above 1.70% for the first time since April 2021.

Our take

A shift in Fed policy often injects volatility into markets. Indeed, this is one of the key points we discussed in our 2022 outlook and is a reason behind why we are looking for more moderate market returns and more normal pullbacks.

That said, stocks have generally had positive performance during periods where the Fed is raising short-term rates because this is normally paired with a healthy economy. A growing economy supports corporate profit growth, which supports the stock market.

Moreover, with U.S. GDP output above pre-pandemic levels, annual job gains in 2021 at a record level, and inflation well above average, it’s hard to justify maximum monetary policy accommodation when the economy is no longer in crisis.

However, it will be a long time before one could argue that Fed policy is restrictive, especially when one considers that yields after inflation, known as real yields, remain in deeply-negative territory. This stands in sharp contrast to 2018, when markets had a sharp selloff late in the year when real yields were slightly positive and investors were concerned the Fed was becoming too aggressive.

Notably, stocks have risen at an average annualized rate of 9% during the 12 Fed rate hike cycles since the 1950s and showed positive returns in 11 of those instances. The one exception was the 1972-1974 period, which coincided with the 1973-1975 recession. Our work suggests near-term recession risks remain low.

Likewise, stocks have generally risen during periods of rising 10-year U.S. Treasury yields. In a study of 15 periods where intermediate rates rose by at least 1.5 percentage points since 1950, stocks averaged an annualized gain of 12%. The exceptions have coincided with recessions or economic slowdowns.

Importantly, intermediate-term rates are only back to pre-pandemic levels. This is certainly justified in our view given the aforementioned economic and inflation backdrop. It’s also consistent with our fixed income team’s outlook for higher rates and higher volatility.

Even with the recent rise in 10-year yields and stocks, the equity risk premium, a metric that compares the valuation of stocks to bonds, remains at a level that has historically corresponded with stocks outperforming bonds on a 12-month basis by an average of almost 11%. Accordingly, we do not see the current level of the 10-year U.S. Treasury yield as a significant threat to the bull market.

To read the publication in its entirety, please Download PDF

Keith Lerner, CFA, CMT

Co-Chief Investment Officer
Chief Market Strategist
Truist Advisory Services, Inc.

Shelly Simpson, CFA, CAIA

Senior Investment Strategy Analyst
Portfolio & Market Strategy
Truist Advisory Services, Inc.

How To Use the FORD Method To Get More Clients

How To Use the FORD Method To Get More Clients

As a business developer, I constantly look for new, streamlined ways to improve my methodologies. I recently came across a method that is simplistic in the best way possible (credit to my brother-in-law).

The FORD method is a communication tool that can be used across organizations and industries to improve your relationships and land more clients. FORD is an acronym that stands for Family, Occupation, Recreation, and Dreams.

This technique is meant to be incorporated into your conversations so you can ask the right questions to build trust and more meaningful connections—the focus of my methodologies and what I teach to other business developers.

Let’s dive into each piece of this acronym and how you can apply them in future conversations.

Family

Most people have a family and consider them to be an important part of their lives. Even for people who do not have a traditional family structure, they typically have a community of support in its place. Family can even mean close friends and pets.

As a proud family man, I enjoy incorporating family into conversations with strangers and clients alike. And it is easy to weave family into the conversation without being too personal.

I recommend starting with an anecdote to prompt a question. For example, “I am looking forward to my daughter coming to visit this weekend. Do you have any children?” Or, if you are meeting a couple for the first time, you can ask, “How did you two meet?”

The best situation is when the person brings up their family in conversation without being prompted. Now you have the perfect opportunity to ask more questions. If they mention a child, ask how old they are. If they happen to be the same age as your child, you now have a perfect way to connect with them and discuss shared experiences.

If you already know a person and some of their family background, keep track of what they say and be thoughtful in future conversations. I like to ask how their partner/sibling/child is doing the next time I speak with them.

Just remember to stay away from invasive questions. For example, never ask whether someone is going to have children, when someone is going to get married or move in together, or why they are not close with family or a specific family member. Unless they bring it up themselves, it is none of your business.

 

Occupation

Occupation is the easiest topic to bring up in a professional setting. If you are new to networking, talking about what someone does for a living is a given. Even for seasoned business developers, we often start a conversation with, “What do you do?”

I will not dwell on this topic since it has been covered ad nauseam. However, I will add that although it is important to know what someone does, do not force the entire conversation to surround work. When building trusting and long-term relationships, their occupation should not be the only topic covered.

For me, I like to know what someone does, who they work for, and how I can help. When talking about occupation, my goal is to see if I can help either by way of introduction or by my firm’s legal services.

 

Recreation

Recreation includes everything you like to do outside of work. If you are looking to spice up a conversation, start by asking a simple, “So, what do you like to do outside of work?” or, “What do you like to do on the weekends?”

If the question seems abrupt, weave a personal story into the conversation to lead into the question like, “I like to start my mornings with a swim. Do you play any sports?” or, “I just got back from a trip to Florida to escape the cold weather for a bit. Do you like to travel?”

Even if the person has completely different interests than you, this will make for better conversation. Get curious about their recreational hobbies and ask questions. In the end, they will appreciate your interest in them and will leave the conversation feeling more energized and valued.

 

Dreams

Everyone has dreams, whether it is about their career or different aspects of their life. For those of you who are not a fan of small talk, this topic can quickly lead into deeper, more meaningful conversations. Although, I like to reserve this topic for a later conversation with someone, not for our first introductory meeting.

When I incorporate dreams into conversation, I ask a question like, “Where do you see yourself/your business in five years?” This usually leads into the perfect opportunity for me to offer my firm’s legal services or a helpful introduction.

Author: Jim Ries jries@offitkurman.com

Right to Know Law Tips for Government Contractors

Right to Know Law Tips for Government Contractors

January 13, 2022

Companies that contract with state and local agencies in Pennsylvania can access a lot of information about an agency’s bidding process through strategic Right to Know Law (RTKL) requests.

Under the RTKL, all agency records are presumed to be public and disclosable unless an exemption or privilege applies. There are three key exemptions to be aware of when requesting records relating to the contracting process:

  • 708(b)(26) – A proposal pertaining to agency procurement or disposal of supplies, services or construction prior to the award of the contract or prior to the opening and rejection of all bids; financial information of a bidder or offeror requested in an invitation for bid or request for proposals to demonstrate the bidder’s or offeror’s economic capability; or the identity of members, notes and other records of agency proposal evaluation committees established under 62 Pa.C.S. Sec. 513 (relating to competitive sealed proposals).
  • 708(b)(10)(i)(A) – records reflecting “the internal, pre-decisional deliberations of an agency, its members, employees or officials or pre-decisional deliberations between agency members, employees or officials and members, employees or officials of another agency, including pre-decisional deliberations relating to a budget recommendation, legislative proposal, legislative amendment, contemplated or proposed policy or course of action or any research, memos or other documents used in the pre-decisional deliberations.”
  • 708(b)(11) – a record that constitutes or reveals a trade secret or confidential, proprietary information.

Section 708(b)(26) is specific to the procurement process. You cannot use the RTKL to get a copy of your competitor’s bid during the bidding process. Furthermore, if your company submits financial information to show its economic capability, your competitors cannot access that information via the RTKL.

Section 708(b)(10)(i)(A), the exemption for the agency’s internal pre-decisional deliberations, prevents access to documents reflecting the agency’s deliberative process. This makes it difficult, if not impossible, to access the agency’s internal emails or notes discussing the merits of the bids it has received for a project, even after the bid has been awarded.

Finally, Section 708(b)(11) protects a bidder’s trade secrets and confidential, proprietary information. To the extent their bid included confidential, proprietary information (e.g., technical information about their product or service, component pricing, or other sensitive data), that information should be redacted before a copy of their bid is released.

Notwithstanding the above exceptions, government contractors can still access useful information. You can request copies of all proposals for a prior version of a contract you intend to bid on to see what other companies have put forth, who the repeat players are, and what good and bad bids have been put forth. If you’re interested in learning more about a particular competitor, you can request all bids that the company has submitted for any project with the agency (excluding currently open bids).

Government contractors are not restricted to requesting bidding information only. You can request communications between the agency and its contractors, which may help you analyze the nature and strength of that relationship. Contractors should think creatively about the types of documents that would help them strategize and gain a competitive advantage. Consulting with counsel when drafting and submitting your request can also streamline the process and ensure you are requesting the information you are entitled to receive.

Author: mshannon@offitkurman.com | 267.338.1328

Understanding Early vs. Late-Stage Alzheimer’s Disease — and Why It’s Important

Understanding Early vs. Late-Stage Alzheimer’s Disease — and Why It’s Important

An estimated 5.8 million Americans age 65 and older live with Alzheimer’s disease (AD), a progressive disease that destroys memory and other important mental functions, with projections showing that by 2050 that number will reach 12.7 million.

AD tends to progress slowly in three general stages: early or mild cognitive impairment (MCI), moderate and severe. Because AD affects people in different ways, each person may experience symptoms — or progress through the stages — differently. On average, a person with AD lives four to eight years after diagnosis, but can live as long as 20 years, depending on other factors.

An early diagnosis of AD is important because it can help determine if the symptoms a patient is experiencing are genuinely due to AD or some other conditions that can be curable or managed with different interventions.  Unfortunately, accurately diagnosing AD in people with MCI is challenging as data suggest that only about 40% of people diagnosed with MCI develop AD over 10 years.

SYNAPS Dx’s DISCERN™ is the world’s first easy-to-administer test that can accurately identify AD at the earliest stages of onset by testing for the presence of three key proprietary biomarkers that are unique to AD.

Why Early Diagnosis Matters

An early AD diagnosis allows patients to start clinical interventions sooner, saving time, money, and the despair of caregivers and patients not knowing what is happening medically. Early diagnosis also gives patients the chance to have a say in their care.  Moreover, newer disease modifying treatments for AD are indicated for MCI or early-stage dementia, where the progression to AD is less clear and diagnosis is less accurate. Now that there are more treatment options becoming available, having an accurate diagnosis of AD earlier in the disease is of greater importance.

Primary healthcare professionals play an important role in recognizing individuals at risk, suggesting lifestyle changes that can prevent or slow down the disease and making a timely diagnosis and initiating treatment that can significantly delay its progression. Early intervention is the optimal strategy because it preserves the patient’s level of function for longer.

Until the launch of DISCERN™, only autopsy findings at death provided a definitive diagnosis of AD in people who lived with dementia. What’s more, AD often co-develops with other age-related neurological disorders, such as Parkinson’s disease, strokes, and different types of dementias.

Value of Accurate AD Test 

DISCERN™ is designed to accurately assess the loss of synaptic activity in the brain, where memories lie, due to AD. The loss of synaptic activity eventually leads to loss in memory, language, reasoning and social behavior, which are common in those with AD.

Our assays have demonstrated >95% sensitivity and specificity. Giving patients and families the answers they need enables providers to make a conclusive diagnosis and informed treatment decisions and allows payers to establish protocols and prior authorizations for prescribing and reimbursing treatment. It also helps pharmaceutical companies identify appropriate clinical trial participants.

Think of DISCERN™ as a tool to manage appropriate patient access to future approved therapies, in addition to the clinical and economic benefits of improved early, accurate diagnosis.

Posted by
Michael Tunkelrott
Author Bio
Michael Tunkelrott is Vice President of Marketing at SYNAPS Dx.